# Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer

> **NCT01835977** · PHASE2 · UNKNOWN · sponsor: **Clinical Research Office of the Endourological Society** · enrollment: 106 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DEVICE:** Irreversible Electroporation (Nanoknife)

## Key facts

- **NCT ID:** NCT01835977
- **Lead sponsor:** Clinical Research Office of the Endourological Society
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-06
- **Primary completion:** 2020-01-30
- **Final completion:** 2025-01
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2020-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01835977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01835977, "Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01835977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*